1. Home
  2. BGIN vs EOLS Comparison

BGIN vs EOLS Comparison

Compare BGIN & EOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BGIN

Bgin Blockchain Limited Class A Ordinary Shares

N/A

Current Price

$2.44

Market Cap

332.6M

Sector

N/A

ML Signal

N/A

Logo Evolus Inc.

EOLS

Evolus Inc.

HOLD

Current Price

$3.96

Market Cap

284.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BGIN
EOLS
Founded
2019
2012
Country
Singapore
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
332.6M
284.3M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
BGIN
EOLS
Price
$2.44
$3.96
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$15.50
AVG Volume (30 Days)
6.3K
1.6M
Earning Date
04-10-2026
03-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
1.23
EPS
N/A
N/A
Revenue
N/A
$297,176,000.00
Revenue This Year
N/A
$13.37
Revenue Next Year
N/A
$17.56
P/E Ratio
N/A
N/A
Revenue Growth
N/A
11.61
52 Week Low
$2.08
$3.98
52 Week High
$5.19
$12.51

Technical Indicators

Market Signals
Indicator
BGIN
EOLS
Relative Strength Index (RSI) 41.44 31.93
Support Level N/A N/A
Resistance Level $2.99 $4.99
Average True Range (ATR) 0.16 0.24
MACD -0.05 -0.11
Stochastic Oscillator 34.78 5.50

Price Performance

Historical Comparison
BGIN
EOLS

About BGIN Bgin Blockchain Limited Class A Ordinary Shares

BGIN Blockchain Ltd is operating through its subsidiaries and is engaged in digital asset technology company based in Singapore, Hong Kong and the U.S. with proprietary cryptocurrency-mining technologies and a strategic focus on alternative cryptocurrencies. It design and sell mining machines equipped with proprietary 8nm or 12nm ASIC chips under different series dedicated to the mining of KAS coins, ALPH coins, and RXD coins. The Company operated in two reportable segments, which were the cryptocurrency mining and the sale of mining machines Key revenue is generated from Sale of mining machines. Geographically, It derives key revenue from Hong Kong, China and Vietnam, United States, Singapore, etc.

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company offering medical aesthetic products in the cash-pay aesthetic market. The company's commercially available products represent two product categories within medical aesthetics: injectable neurotoxins and injectable hyaluronic acid (HA) gels. Its commercial products are: Jeuveau, a proprietary 900-kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe frown lines, in adults; and Evolysse, a collection of injectable HA gels that utilizes first-generation cold technology. The line includes several products, including mid face, nasolabial folds, lips, and eyes. Geographically, the company currently has operations in the United States, Canada, Europe, and Australia.

Share on Social Networks: